FdaApplication

ANDA 209639

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBIOCON PHARMA LTD
application_typeANDA
approval_date2023-03-13

Products (2)

ProductActive ingredientStrengthDosage form
TERIFLUNOMIDETERIFLUNOMIDE14MGTABLET;ORAL
TERIFLUNOMIDETERIFLUNOMIDE7MGTABLET;ORAL

2 products